Allurion Technologies Inc. (ALUR)
NYSE: ALUR · Real-Time Price · USD
2.680
-0.080 (-2.90%)
At close: Aug 8, 2025, 4:00 PM
2.680
0.00 (0.00%)
After-hours: Aug 8, 2025, 7:00 PM EDT

Company Description

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight.

Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.

The company operates in Spain, France, Turkey, and internationally. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

Allurion Technologies Inc.
Allurion Technologies logo
CountryUnited States
Founded2009
IndustryMedical Devices
SectorHealthcare
Employees137
CEOShantanu Gaur

Contact Details

Address:
11 Huron Drive
Natick, Massachusetts 01760
United States
Phone508 647 4000
Websiteallurion.com

Stock Details

Ticker SymbolALUR
ExchangeNYSE
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001964979
CUSIP Number02008G102
ISIN NumberUS02008G2012
SIC Code3841

Key Executives

NamePosition
Dr. Shantanu K. Gaur M.D.Co-Founder, Chief Executive Officer, President, Principal Financial and Accounting Officer and Director
Ojas A. BuchChief Operating Officer
Brendan Michael Gibbons J.D.Chief Legal Officer and Corporate Secretary
Dr. Samuel G. LevyCo-Founder
Dr. Ram Chuttani M.D.MD, Chief Medical Officer and Founding Partner
Matt WrightVice President of People
Adrian WildSenior Vice President of International Commercial

Latest SEC Filings

DateTypeTitle
Aug 7, 2025424B3Prospectus
Aug 7, 2025424B3Prospectus
Aug 7, 20258-KCurrent Report
Jun 18, 2025S-8Securities to be offered to employees in employee benefit plans
May 20, 2025424B3Prospectus
May 20, 2025424B3Prospectus
May 15, 202510-QQuarterly Report
May 15, 2025SCHEDULE 13G/AFiling
May 14, 20258-KCurrent Report
May 9, 2025EFFECTNotice of Effectiveness